Figure 5. Correlations between: A) % change in arachidonic acid (ARA, 20:4n6) cyclooxygenase metabolite prostaglandin F2α (PGF2α) and % change in phosphatidylcholine (PC) concentrations of ARA; B) % change in eicosapentaenoic acid (EPA, 20:5n3) soluble epoxide hydrolase (sEH) metabolite 17,18-dihydroxyeicosatrienoic acid (17,18-DiHETE) and % change in triglyceride (TG) concentrations of EPA; C) % change in docosahexaenoic acid (DHA, 22:6n3) sEH metabolite 10,11-dihydroxydocosapentaenoic acid (10,11-DiHDPE) and % change in free fatty acid (FFA) concentrations of DHA; D) % change in PE concentrations of DHA and baseline PE ARA %.
